Erstellt von fchar99
Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences Corp.
WKN: 936853 / Symbol: EW / Name: Edwards Lifesciences / Aktie / Ausrüstung & Versorgung / Large Cap /
73,15 €
-0,94 %
Edwards Lifesciences Corporation (NYSE: EW) had its price target raised by analysts at Wells Fargo & Company from $80.00 to $84.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Corporation (NYSE: EW) had its price target raised by analysts at Royal Bank Of Canada from $85.00 to $89.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Corporation (NYSE: EW) had its price target raised by analysts at Piper Sandler from $83.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Corporation (NYSE: EW) had its price target raised by analysts at Barclays PLC from $90.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Corporation (NYSE: EW) had its price target raised by analysts at Stifel Nicolaus from $90.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Corporation (NYSE: EW) had its price target raised by analysts at Mizuho from $87.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Corporation (NYSE: EW) had its "buy" rating re-affirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Corporation (NYSE: EW) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $100.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Corporation (NYSE: EW) had its price target raised by analysts at Wells Fargo & Company from $84.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) was given a new $88.00 price target on by analysts at Evercore ISI. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Evercore ISI from $88.00 to $92.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Stifel Nicolaus from $85.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Royal Bank Of Canada from $89.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $95.00 price target on the stock, up previously from $90.00.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Citigroup Inc. from $95.00 to $96.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $100.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Royal Bank Of Canada from $95.00 to $100.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $90.00.
Ratings data for EW provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in M&T Bank Corp. diskutieren